[Federal Register Volume 83, Number 146 (Monday, July 30, 2018)]
[Notices]
[Pages 36607-36608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2014-N-1069; FDA-2017-N-6931; FDA-2011-N-0362; FDA-
2011-N-0279; FDA-2011-N-0672; FDA-2014-N-0913; FDA-2017-N-0493; and 
FDA-2011-N-0781]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approvals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
information collections that have been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-7726, 
[email protected].

SUPPLEMENTARY INFORMATION: The following is a list of FDA information 
collections recently approved by OMB under section 3507 of the 
Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control 
number and expiration date of OMB approval for each information 
collection are shown in table 1. Copies of the supporting statements 
for the information collections are available on the internet at 
https://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or 
sponsor, and a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.

[[Page 36608]]



        Table 1--List of Information Collections Approved by OMB
------------------------------------------------------------------------
                                            OMB control    Date approval
           Title of collection                  No.           expires
------------------------------------------------------------------------
Blood Establishment Registration and           0910-0052       6/30/2021
 Product Listing for Manufacturers of
 Human Blood and Blood Products and
 Licensed Devices; Form FDA 2830........
Current Good Manufacturing Practices and       0910-0116       6/30/2021
 Related Regulations for Blood and Blood
 Components; and Requirements for
 Donation Testing, Donor Notification,
 and ``Lookback''.......................
Current Good Manufacturing Practices for       0910-0139       6/30/2021
 Finished Pharmaceuticals and Medical
 Gases..................................
Prescription Drug Marketing.............       0910-0435       6/30/2021
Prominent and Conspicuous Mark of              0910-0577       6/30/2021
 Manufacturers on Single-Use Devices....
Guidance FDA and Industry Procedures for       0910-0705       6/30/2021
 Section 513(g) Requests for Information
 under the Federal Food, Drug, and
 Cosmetic Act...........................
Utilization of Adequate Provision Among        0910-0853       6/30/2021
 Low to Non-Internet Users..............
Record Retention Requirements for the          0910-0428       7/31/2021
 Soy Protein/Coronary Heart Disease
 Health Claim...........................
------------------------------------------------------------------------


    Dated: July 24, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-16156 Filed 7-27-18; 8:45 am]
 BILLING CODE 4164-01-P